APA (7th ed.) Citation

MR, B., C, O., M, S., B, R., Y, M., KC, B., . . . TF, G. (2025). Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME. Immunity, 58(4), 926. https://doi.org/10.1016/j.immuni.2025.02.017

Chicago Style (17th ed.) Citation

MR, Benmebarek, et al. "Anti-vascular Endothelial Growth Factor Treatment Potentiates Immune Checkpoint Blockade Through a BAFF- and IL-12-dependent Reprogramming of the TME." Immunity 58, no. 4 (2025): 926. https://doi.org/10.1016/j.immuni.2025.02.017.

MLA (9th ed.) Citation

MR, Benmebarek, et al. "Anti-vascular Endothelial Growth Factor Treatment Potentiates Immune Checkpoint Blockade Through a BAFF- and IL-12-dependent Reprogramming of the TME." Immunity, vol. 58, no. 4, 2025, p. 926, https://doi.org/10.1016/j.immuni.2025.02.017.